• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

镍化合物在水、大鼠血清和肾细胞溶质中的溶解半衰期。

Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol.

作者信息

Kuehn K, Sunderman F W

出版信息

J Inorg Biochem. 1982 Aug;17(1):29-39. doi: 10.1016/s0162-0134(00)80227-5.

DOI:10.1016/s0162-0134(00)80227-5
PMID:7119773
Abstract

Seventeen nickel compounds were incubated in water, rat serum, and rat renal cytosol for 72 hr at 37 degrees C. Concentrations of dissolved nickel were analyzed by electrothermal atomic absorption spectrophotometry, and dissolution half-times (T50) were computed by the Weibull equation. Eleven of the nickel compounds (Ni, beta NiS, amorphous NiS, alpha Ni3S2, NiSe, Ni3Se2, NiTe, NiAs, Ni11As8, Ni5As2, and NiFeS4) dissolved more rapidly in serum or cytosol than in water. Four of the compounds (NiO, NiSb, NiFe alloy, and NiTiO3) had no detectable dissolution in any of the media (i.e., T50 greater than 11 yr). One compound (NiAsS) had approximately equal T50 values in the three media; the T50 value of one compound (NiS2) could not be determined in serum or cytosol owing to precipitation. T50 value of 34 and 21 days for dissolution of alpha Ni3S2 in serum and cytosol, respectively, agree closely with the excretion half-time of 24 days derived from previously reported data for excretion of 63Ni in urine and feces of rats after intramuscular injection of alpha 63Ni3S2. These findings suggest that in vitro dissolution half-times of nickel compounds may be used to predict their in vivo excretion half-times, since the dissolution process is rate-limiting to their metabolism and excretion.

摘要

将17种镍化合物于37℃在水、大鼠血清和大鼠肾细胞溶质中孵育72小时。通过电热原子吸收分光光度法分析溶解镍的浓度,并通过威布尔方程计算溶解半衰期(T50)。11种镍化合物(Ni、β-NiS、非晶态NiS、α-Ni3S2、NiSe、Ni3Se2、NiTe、NiAs、Ni11As8、Ni5As2和NiFeS4)在血清或细胞溶质中的溶解速度比在水中更快。4种化合物(NiO、NiSb、NiFe合金和NiTiO3)在任何一种介质中均未检测到溶解(即T50大于11年)。一种化合物(NiAsS)在三种介质中的T50值大致相等;一种化合物(NiS2)由于沉淀而无法在血清或细胞溶质中测定T50值。α-Ni3S2在血清和细胞溶质中的溶解T50值分别为34天和21天,这与先前报道的肌肉注射α-63Ni3S2后大鼠尿液和粪便中63Ni排泄的24天排泄半衰期密切相符。这些发现表明,镍化合物的体外溶解半衰期可用于预测其体内排泄半衰期,因为溶解过程是其代谢和排泄的限速步骤。

相似文献

1
Dissolution half-times of nickel compounds in water, rat serum, and renal cytosol.镍化合物在水、大鼠血清和肾细胞溶质中的溶解半衰期。
J Inorg Biochem. 1982 Aug;17(1):29-39. doi: 10.1016/s0162-0134(00)80227-5.
2
Phagocytosis of particulate nickel compounds by rat peritoneal macrophages in vitro.大鼠腹腔巨噬细胞对颗粒状镍化合物的体外吞噬作用。
Carcinogenesis. 1982;3(3):321-6. doi: 10.1093/carcin/3.3.321.
3
Carcinogenicity of nickel compounds in animals.
IARC Sci Publ. 1984(53):127-42.
4
Association between erythrocytosis and renal cancers in rats following intrarenal injection of nickel compounds.
Carcinogenesis. 1984 Nov;5(11):1511-7. doi: 10.1093/carcin/5.11.1511.
5
Mechanisms of dissolution of nickel subsulfide in rat serum.硫化亚镍在大鼠血清中的溶解机制。
Res Commun Chem Pathol Pharmacol. 1977 Jan;16(1):95-108.
6
Carcinogenesis tests of nickel arsenides, nickel antimonide, and nickel telluride in rats.大鼠中砷化镍、锑化镍和碲化镍的致癌性试验。
Cancer Invest. 1983;1(6):469-74. doi: 10.3109/07357908309020271.
7
Effects of manganese on carcinogenicity and metabolism of nickel subsulfide.锰对硫化亚镍致癌性及代谢的影响。
Cancer Res. 1976 May;36(5):1790-800.
8
63Nickel-constituents in renal cytosol of rats after injection of 63nickel chloride.
Ann Clin Lab Sci. 1981 Nov-Dec;11(6):488-96.
9
Lung clearance and disposition of 63Ni in F344/N rats after intratracheal instillation of nickel sulfate solutions.气管内滴注硫酸镍溶液后F344/N大鼠肺部对⁶³Ni的清除及分布情况
Environ Res. 1987 Jun;43(1):168-78. doi: 10.1016/s0013-9351(87)80068-3.
10
Carcinogenesis bioassays of nickel oxides and nickel-copper oxides by intramuscular administration to Fischer-344 rats.通过对Fischer-344大鼠进行肌肉注射来开展氧化镍和氧化镍-氧化铜的致癌生物测定。
Res Commun Chem Pathol Pharmacol. 1990 Oct;70(1):103-13.

引用本文的文献

1
Carcinogenic effect of nickel compounds.镍化合物的致癌作用。
Mol Cell Biochem. 2005 Nov;279(1-2):45-67. doi: 10.1007/s11010-005-8215-2.
2
Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas.镍转化的小鼠细胞和镍诱导的鼠肉瘤中Fhit蛋白表达降低。
Mol Cell Biochem. 2004 Jan;255(1-2):195-202. doi: 10.1023/b:mcbi.0000007275.22785.91.
3
Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds.颗粒状和可溶性镍化合物的毒性、摄取及致突变性。
Environ Health Perspect. 1994 Sep;102 Suppl 3(Suppl 3):69-79. doi: 10.1289/ehp.94102s369.
4
In vitro toxicity and transformation potency of nickel compounds.镍化合物的体外毒性和转化能力。
Environ Health Perspect. 1983 Sep;51:223-6. doi: 10.1289/ehp.8351223.
5
The accumulation of nickel in human lungs.镍在人肺中的蓄积。
Environ Health Perspect. 1989 May;81:221-4. doi: 10.1289/ehp.8981221.